BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zychowska M, Rojewska E, Piotrowska A, Kreiner G, Nalepa I, Mika J. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target – Evidence from a mouse diabetic neuropathy model. International Immunopharmacology 2017;52:261-71. [DOI: 10.1016/j.intimp.2017.09.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruff MR, Inan S, Shi XQ, Meissler JJ, Adler MW, Eisenstein TK, Zhang J. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103. Life Sci 2022;306:120788. [PMID: 35817166 DOI: 10.1016/j.lfs.2022.120788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fang X, Wang H, Song H, Wang J, Zhang Z. Neuroinflammation Involved in Diabetes-Related Pain and Itch. Front Pharmacol 2022;13:921612. [DOI: 10.3389/fphar.2022.921612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Saito M, Suzuki H, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of an Anti-Mouse CCR8 Monoclonal Antibody (C8Mab-1) for Flow Cytometry and Immunocytochemistry. Monoclon Antib Immunodiagn Immunother 2022. [PMID: 35483056 DOI: 10.1089/mab.2021.0069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vincenzi M, Milella MS, D’ottavio G, Caprioli D, Reverte I, Maftei D. Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain. Life 2022;12:398. [DOI: 10.3390/life12030398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Nalisa M, Nweke EE, Smith MD, Omoshoro-Jones J, Devar JW, Metzger R, Augustine TN, Fru PN. Chemokine receptor 8 expression may be linked to disease severity and elevated interleukin 6 secretion in acute pancreatitis. World J Gastrointest Pathophysiol 2021; 12(6): 115-133 [PMID: 34877026 DOI: 10.4291/wjgp.v12.i6.115] [Reference Citation Analysis]
6 Piotrowska A, Ciapała K, Pawlik K, Kwiatkowski K, Rojewska E, Mika J. Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-In Vivo and In Vitro Study. Int J Mol Sci 2021;22:11074. [PMID: 34681732 DOI: 10.3390/ijms222011074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 García-Domínguez M, González-Rodríguez S, Hidalgo A, Baamonde A, Menéndez L. Kappa-opioid receptor-mediated thermal analgesia evoked by the intrathecal administration of the chemokine CCL1 in mice. Fundam Clin Pharmacol 2021. [PMID: 33905573 DOI: 10.1111/fcp.12685] [Reference Citation Analysis]
8 Calcutt NA. Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms? Pain 2020;161:S65-86. [PMID: 32999525 DOI: 10.1097/j.pain.0000000000001922] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
9 Mesquida-Veny F, Del Río JA, Hervera A. Macrophagic and microglial complexity after neuronal injury. Prog Neurobiol 2021;200:101970. [PMID: 33358752 DOI: 10.1016/j.pneurobio.2020.101970] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
10 Bogacka J, Ciapała K, Pawlik K, Dobrogowski J, Przeklasa-Muszynska A, Mika J. Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia - Evidence from a Mouse Model of Diabetic Neuropathy. Neuroscience 2020;441:77-92. [PMID: 32592824 DOI: 10.1016/j.neuroscience.2020.06.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jiang B, Liu T, Gao Y. Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential. Pharmacology & Therapeutics 2020;212:107581. [DOI: 10.1016/j.pharmthera.2020.107581] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 27.0] [Reference Citation Analysis]
12 Zajaczkowska R, Kwiatkowski K, Pawlik K, Piotrowska A, Rojewska E, Makuch W, Wordliczek J, Mika J. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain. Pharmacol Rep 2020;72:1310-22. [PMID: 32691345 DOI: 10.1007/s43440-020-00137-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wang C, Xu R, Wang X, Li Q, Li Y, Jiao Y, Zhao Q, Guo S, Su L, Yu Y, Yu Y. Spinal CCL1/CCR8 regulates phosphorylation of GluA1-containing AMPA receptor in postoperative pain after tibial fracture and orthopedic surgery in mice. Neuroscience Research 2020;154:20-6. [DOI: 10.1016/j.neures.2019.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides 2020;124:170223. [DOI: 10.1016/j.peptides.2019.170223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
15 Liu S, Liu X, Xiong H, Wang W, Liu Y, Yin L, Tu C, Wang H, Xiang X, Xu J, Duan B, Tao A, Zhao Z, Mei Z. CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice. Brain, Behavior, and Immunity 2019;80:711-24. [DOI: 10.1016/j.bbi.2019.05.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
16 Kwiatkowski K, Popiolek-barczyk K, Piotrowska A, Rojewska E, Ciapała K, Makuch W, Mika J. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia. Cytokine 2019;119:202-13. [DOI: 10.1016/j.cyto.2019.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
17 García-domínguez M, Aguirre A, Lastra A, Hidalgo A, Baamonde A, Menéndez L. The Systemic Administration of the Chemokine CCL1 Evokes Thermal Analgesia in Mice Through the Activation of the Endocannabinoid System. Cell Mol Neurobiol 2019;39:1115-24. [DOI: 10.1007/s10571-019-00706-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rojewska E, Ciapała K, Mika J. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model. Pharmacological Reports 2019;71:139-48. [DOI: 10.1016/j.pharep.2018.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
19 Jorda A, Cauli O, Santonja JM, Aldasoro M, Aldasoro C, Obrador E, Vila JM, Mauricio MD, Iradi A, Guerra-Ojeda S, Marchio P, Valles SL. Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease. Int J Biol Sci 2019;15:453-63. [PMID: 30745834 DOI: 10.7150/ijbs.26703] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
20 Salat K, Gryzlo B, Kulig K. Experimental Drugs for Neuropathic Pain. Curr Neuropharmacol 2018;16:1193-209. [PMID: 29745335 DOI: 10.2174/1570159X16666180510151241] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
21 Rojewska E, Zychowska M, Piotrowska A, Kreiner G, Nalepa I, Mika J. Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine. Front Immunol 2018;9:494. [PMID: 29593735 DOI: 10.3389/fimmu.2018.00494] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
22 Kwiatkowski K, Mika J. The importance of chemokines in neuropathic pain development and opioid analgesic potency. Pharmacol Rep 2018;70:821-30. [PMID: 30122168 DOI: 10.1016/j.pharep.2018.01.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]